Brief: N4 Pharma Announces Collaboration Agreement With SRI International
April 25 (Reuters) - N4 Pharma PLC N4P.L :
* COLLABORATION AGREEMENT WITH SRI INTERNATIONAL INC
Source text for Eikon: ID:nRSY0062Ma
Further company coverage: N4P.L
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Thalia Therapeutics
See all newsThalia Therapeutics - Interim Results
Brief: Thalia Therapeutics Says New Patent Granted For Miristen In China
Thalia Therapeutics - New Patent Granted for miRisten in China
Thalia Therapeutics - RNA gene-silencing cardiovascular program advances
Thalia Therapeutics - Business Update and Notice of Results